7.6
Le modèle à un compartiment : la perfusion IV
La perfusion intraveineuse (IV) est souvent utilisée lorsqu'une administration continue et contrôlée de médicaments est nécessaire, comme lors d'une i…
La perfusion IV convient lorsque le maintien d’une concentration constante et stable du médicament dans l’organisme est souhaité ou lorsque le médicament présente des risques de toxicité.
Par exemple, la perfusion IV est utilisée pour les antibiotiques, où le contrôle de la posologie est essentiel.
Dans un modèle à un compartiment, le taux de variation de la quantité de médicament dans le corps est égal à la différence entre les taux de perfusion et d’élimination, représentée mathématiquement par les équations données.
L’équilibre d’équilibre est atteint lorsque le taux de perfusion du médicament est égal à son taux d’élimination.
La constante de vitesse d’élimination, un paramètre pharmacocinétique crucial, peut être déterminée à partir du graphique semi-log concentration-temps plasmatique, en calculant la pente de la droite.
Le volume apparent de distribution et la clairance systémique totale, deux paramètres pharmacocinétiques critiques, peuvent être estimés à l’aide de la concentration à l’état d’équilibre et du débit de perfusion.
Ils peuvent également être calculés à partir de l’aire totale sous la courbe jusqu’à la fin de l’infusion.
View the full transcript and gain access to JoVE Core videos
Q1: When is IV infusion preferred over other drug administration routes?
IV infusion is preferred when maintaining constant and stable drug concentration is critical, such as with antibiotics where dosage control is essential. It is also used when drugs pose toxicity risks, allowing precise control and immediate drug action while bypassing first-pass metabolism.
Q2: What happens at steady-state in a one-compartment IV infusion model?
At steady-state or infusion equilibrium, the rate of drug infusion equals the elimination rate, resulting in constant drug concentration in the body. This balanced state occurs when drug input and output are equal, preventing further drug accumulation despite continued infusion administration.
Q3: How is the elimination rate constant determined from plasma concentration data?
The elimination rate constant, a crucial pharmacokinetic parameter, is determined from a semilog plasma concentration-time plot by calculating the slope of the line. This value is essential for understanding drug removal kinetics and predicting how plasma concentration changes over time during and after infusion.
Q4: What pharmacokinetic parameters can be estimated from steady-state infusion data?
Apparent volume of distribution and total systemic clearance can be estimated using steady-state concentration and infusion rate. These critical metrics can also be computed from the total area under the curve until the end of infusion, enabling accurate dosage regimen design.
Q5: Why is a loading dose sometimes administered with IV infusion?
A loading dose is administered when rapid therapeutic concentration is needed, allowing the drug to reach effective levels quickly. The combined impact of both the loading dose and infusion can be calculated using specific mathematical equations to achieve desired plasma concentrations.
Q6: How do mathematical equations describe drug quantity changes in the one-compartment model?
In the one-compartment model, the rate of change in drug amount equals the difference between infusion and elimination rates. These mathematical equations form the foundation for predicting drug behavior and are essential for understanding how infusion rate and elimination kinetics determine plasma concentration profiles.
Q7: What is the relationship between elimination rate constant and half-life in IV infusion?
The elimination rate constant, k, directly determines half-life and clearance, which are derived pharmacokinetic parameters essential for dosage design. These calculations from k are crucial for predicting how long therapeutic concentrations persist after infusion stops and ensuring safe and effective drug therapy.